Peptide YY

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Current Opinion in Endocrinology, Diabetes & Obesity

• Publication date

  2008-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/MED.0b013e3282f3f4b1PMID 18185065
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Peptide YY levels are associated with appetite suppression in response to long-chain fatty acids.

  2008cited by this paper
• Interaction of Dietary composition and PYY gene expression in diet-induced obesity in rats

  2008cited by this paper
• Peptide YY release in anorectic patients after liquid meal.

  2007cited by this paper
• Gastrointestinal regulation of food intake.

  2007cited by this paper
• Efficacy and safety of intranasal peptide YY3-36 for weight reduction in obese adults.

  2007cited by this paper
• Peptide YY regulates bone turnover in rodents.

  2007cited by this paper
• Peptide YY (3-36) Represents a High Percentage of Total PYY Immunoreactivity in Preterm and Full-Term Infants and Correlates Independently With Markers of Adiposity and Serum Ghrelin Concentrations

  2007cited by this paper
• Involvement of apolipoprotein A-IV and cholecystokinin1 receptors in exogenous peptide YY3 36-induced stimulation of intestinal feedback.

  2007cited by this paper
• Basal and postprandial gut peptides affecting food intake in lean and obese pregnant women.

  2007cited by this paper
• PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans

  2007cited by this paper
• Decreased plasma peptide YY accompanied by elevated peptide YY and Y2 receptor binding densities in the medulla oblongata of diet-induced obese mice.

  2007cited by this paper
• Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.

  2007cited by this paper
• Interactions between the "cognitive" and "metabolic" brain in the control of food intake.

  2007cited by this paper
• Intermittent intraperitoneal infusion of peptide YY(3-36) reduces daily food intake and adiposity in obese rats.

  2007cited by this paper
• Neuropeptide Y (NPY) Y2 receptor-selective agonist inhibits food intake and promotes fat metabolism in mice: combined anorectic effects of Y2 and Y4 receptor-selective agonists.

  2007cited by this paper
• Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36.

  2007cited by this paper
• Effect of macronutrient composition on postprandial peptide YY levels.

  2007cited by this paper
• Peptide YY3-36 Decreases Reinstatement of High-Fat Food Seeking during Dieting in a Rat Relapse Model

  2007cited by this paper
• A long-acting selective neuropeptide Y2 receptor PEGylated peptide agonist reduces food intake in mice.

  2007cited by this paper
• Incomplete restoration of the secretion of ghrelin and PYY compared to insulin after food ingestion following weight gain in anorexia nervosa.

  2007cited by this paper
• Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice.

  2007cited by this paper
• Novel selective neuropeptide Y2 receptor PEGylated peptide agonists reduce food intake and body weight in mice.

  2007cited by this paper
• Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects.

  2007cited by this paper
• Elevated peptide YY levels in adolescent girls with anorexia nervosa.

  2006cited by this paper
• Peptide YY3‐36 and pancreatic polypeptide suppress food intake

  2006cited by this paper
• Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects.

  2006cited by this paper
• Differential Effects of Gastric Bypass and Banding on Circulating Gut Hormone and Leptin Levels

  2006cited by this paper
• Physiological Evidence for the Involvement of Peptide YY in the Regulation of Energy Homeostasis in Humans

  2006cited by this paper
• Critical role for peptide YY in protein-mediated satiation and body-weight regulation.

  2006cited by this paper
• PYY[3-36] administration decreases the respiratory quotient and reduces adiposity in diet-induced obese mice.

  2006cited by this paper
• PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity.

  2006cited by this paper
• The importance of acclimatisation and habituation to experimental conditions when investigating the anorectic effects of gastrointestinal hormones in the rat

  2006cited by this paper
• Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters

  2006cited by this paper
• Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity

  2006cited by this paper
• Effects of dipeptidyl peptidase IV on the satiety actions of peptide YY

  2006cited by this paper
• Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats.

  2006cited by this paper
• Attenuated peptide YY release in obese subjects is associated with reduced satiety.

  2006cited by this paper
• Homeostatic and Non‐homeostatic Pathways Involved in the Control of Food Intake and Energy Balance

  2006cited by this paper
• Ghrelin Attenuates the Inhibitory Effects of Glucagon-Like Peptide-1 and Peptide YY(3-36) on Food Intake and Gastric Emptying in Rats

  2006cited by this paper
• Dose-dependent effects of peptide YY(3-36) on conditioned taste aversion in rats.

  2006cited by this paper
• Effect of peptide YY3-36 on food intake in humans.

  2005cited by this paper
• Circulating peptide YY concentrations are higher in preterm than full-term infants and correlate negatively with body weight and positively with serum ghrelin concentrations.

  2005cited by this paper
• Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice.

  2005cited by this paper
• Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats.

  2005cited by this paper
• Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.

  2005cited by this paper
• Energy Homeostasis and Gastrointestinal Endocrine Differentiation Do Not Require the Anorectic Hormone Peptide YY

  2005cited by this paper
• Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys.

  2005cited by this paper
• The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway.

  2005cited by this paper
• Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents.

  2005cited by this paper
• Peptide YY(3-36) inhibits morning, but not evening, food intake and decreases body weight in rhesus macaques.

  2005cited by this paper
• Intravenous Peptide YY3‐36 and Y2 Receptor Antagonism in the Rat: Effects on Feeding Behaviour

  2005cited by this paper
• Peptide YY is a regulator of energy homeostasis in obese children before and after weight loss.

  2005cited by this paper
• Interaction of dietary composition and PYY gene expression in diet-induced obesity in rats.

  2005cited by this paper
• The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats.

  2005cited by this paper
• Reversible PEGylation of peptide YY3‐36 prolongs its inhibition of food intake in mice

  2005cited by this paper
• Peripheral administration of PYY(3-36) produces conditioned taste aversion in mice.

  2005cited by this paper
• Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake.

  2005cited by this paper
• Peptide YY Directly Inhibits Ghrelin-Activated Neurons of the Arcuate Nucleus and Reverses Fasting-Induced c-Fos Expression

  2004cited by this paper
• Comparison of the inhibitory effects of PYY(3-36) and PYY(1-36) on gastric emptying in rats.

  2004cited by this paper
• Peptide YY3-36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism.

  2004cited by this paper
• Enhancement of feeding suppression by PYY(3-36) in rats with area postrema ablations.

  2004cited by this paper
• Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36).

  2004cited by this paper
• Effects of peptide YY[3-36] on short-term food intake in mice are not affected by prevailing plasma ghrelin levels.

  2004cited by this paper
• Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY3–36 but resistant to ghrelin

  2004cited by this paper
• Effects of PYY[3–36] in rodent models of diabetes and obesity

  2004cited by this paper
• Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse.

  2003cited by this paper
• Inhibition of food intake in obese subjects by peptide YY3-36.

  2003cited by this paper
• Peptide YY Secretion in Morbidly Obese Patients Before and After Vertical Banded Gastroplasty

  2002cited by this paper
• Gut hormone PYY3-36 physiologically inhibits food intake

  2002cited by this paper
• Mouse pancreatic polypeptide modulates food intake, while not influencing anxiety in mice.

  1999cited by this paper
• Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36.

  1994cited by this paper
• Effect of peptide YY on gastric, pancreatic, and biliary function in humans.

  1985cited by this paper
• Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides

  1980cited by this paper

• Leptin and G-protein coupled receptor (GPCR) signaling: Therapeutic potential in obesity

  2025cites this paper
• Peptide YY reduces cytotoxicity of Candida albicans in alcohol-associated liver disease

  2025cites this paper
• PYY3-36 infused systemically or directly into the VTA attenuates fentanyl seeking in male rats.

  2023cites this paper
• Hypertension Related to Obesity: Pathogenesis, Characteristics and Factors for Control

  2022cites this paper
• Age-Dependent Neuropsychiatric Symptoms in the NF-κB/c-Rel Knockout Mouse Model of Parkinson’s Disease

  2022cites this paper
• A Novel Dual Agonist of Glucagon-like Peptide-1 Receptors and Neuropeptide Y2 Receptors Attenuates Fentanyl Taking and Seeking in Male Rats.

  2021cites this paper
• A Novel Approach to Treating Opioid Use Disorders: Dual Agonists of Glucagon-like Peptide-1 Receptors and Neuropeptide Y2 Receptors.

  2021cites this paper
• Effect of Bacillus–direct-fed microbial on leaky gut, serum peptide YY concentration, bone mineralization, and ammonia excretion in neonatal female turkey poults fed with a rye-based diet

  2020cites this paper
• Peptide YY3–36 concentration in acute- and long-term recovered anorexia nervosa

  2020cites this paper
• Neuroendocrinology of reward in anorexia nervosa and bulimia nervosa: Beyond leptin and ghrelin.

  2019cites this paper
• Targeting Islets: Metabolic Surgery Is More than a Bariatric Surgery

  2019cites this paper
• Investigating the Effect of Fasting on Appetite Regulatory Hormones in Thin and Obese Females

  2018cites this paper
• Gut Hormones and Regulation of Food Intake in Birds

  2017cites this paper
• Effect of butter content and baking condition on characteristics of the gluten‐free dough and bread

  2017cites this paper
• The Effect of Concurrent Exercise on PYY and NPY Plasma Levels in Obese Men

  2016cites this paper
• The role of the neuropeptide Y (NPY) family in the pathophysiology of inflammatory bowel disease (IBD).

  2016cites this paper
• The Effect of Normobaric Hypoxic Confinement on Metabolism, Gut Hormones, and Body Composition

  2016cites this paper
• PYY3-36: Beyond food intake.

  2015cites this paper
• The use of bimolecular fluorescence complementation (BiFC) to investigate the functional implications of neuropeptide Y receptor dimerisation and beta-arrestin recruitment

  2015cites this paper
• Regulation of Pancreatic Secretion

  2015cites this paper
• The role of gut hormone peptide YY in energy and glucose homeostasis: twelve years on.

  2014cites this paper
• The Y2 receptor agonist PYY(3-36) increases the behavioural response to novelty and acute dopaminergic drug challenge in mice.

  2014cites this paper
• Gut-Brain Endocrine Axes in Weight Regulation and Obesity Pharmacotherapy

  2014cites this paper
• Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors.

  2014cites this paper
• Development of porous silicon nanocarriers for parenteral peptide delivery.

  2013cites this paper
• Peripheral activation of the Y2-receptor promotes secretion of GLP-1 and improves glucose tolerance.

  2013cites this paper
• The Role of Gastrointestinal Hormones in Hepatic Lipid Metabolism

  2013cites this paper
• Hepatic Lipid Metabolism , NAFLD , and Gut Peptides in the Era of Metabolic Syndrome

  2013cites this paper
• Effects of dietary polyphenols on neuroregulatory factors and pathways that mediate food intake and energy regulation in obesity.

  2013cites this paper
• Mesoporous Silicon (PSi) for Sustained Peptide Delivery: Effect of PSi Microparticle Surface Chemistry on Peptide YY3-36 Release

  2012cites this paper
• Shedding pounds after going under the knife: Metabolic insights from cutting the gut

  2012cites this paper
• Role of Y(2) receptors in the regulation of gastric tone in rats.

  2012cites this paper
• THE EFFECTS OF CURCUMIN ON BODY COMPOSITION OF PATIENTS WITH ADVANCED PANCREATIC CANCER

  2011cites this paper
• Influence of resistance and aerobic exercise on hunger, circulating levels of acylated ghrelin, and peptide YY in healthy males.

  2009cites this paper
• Distribution of Peripherally Injected Peptide YY ([125I] PYY (3–36)) and Pancreatic Polypeptide ([125I] hPP) in the CNS: Enrichment in the Area Postrema

  2007cites this paper
• Sucrose fatty acid esters suppress pancreatic secretion accompanied by peptide YY release in pancreatico‐biliary diverted rats

  2007cites this paper
• Gastrointestinal hormones regulating appetite

  2006cites this paper